Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore acts as a non-competitive inhibitor of dynamin's GTPase activity, pivotal for vesicle scission during endocytosis. Its modulatory activity could plausibly attenuate EPSIN3 function via inhibition of vesicular maturation and scission events. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2 impedes clathrin-mediated endocytosis by targeting the terminal domain of clathrin and adaptor protein 2 (AP2). The inhibitor could exert an indirect effect on EPSIN3 by modulating the clathrin lattice assembly process. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine, by perturbing clathrin lattices at the plasma membrane, obstructs clathrin-mediated endocytosis. Its potential impact on EPSIN3 may be a downstream effect due to the disruption of the endocytic machinery. | ||||||
Dansylcadaverine | 10121-91-2 | sc-214851 sc-214851A sc-214851B | 100 mg 250 mg 1 g | $52.00 $89.00 $240.00 | 4 | |
This compound serves as a dual inhibitor, targeting transglutaminase and impeding clathrin-mediated endocytosis, potentially modulating EPSIN3's role in vesicle biogenesis. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein obstructs caveolin-dependent endocytosis. Though its primary mechanism targets caveolae, there exists the potential for a broader modulation of endocytic pathways, including those involving EPSIN3. | ||||||
Nystatin | 1400-61-9 | sc-212431 sc-212431A sc-212431B sc-212431C | 5 MU 25 MU 250 MU 5000 MU | $51.00 $129.00 $251.00 $3570.00 | 7 | |
By selectively binding to cholesterol, Nystatin disrupts lipid raft integrity. While primarily known for caveolae-mediated endocytosis inhibition, potential collateral effects on EPSIN3-mediated processes cannot be ruled out. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
This cholesterol-depleting agent disrupts the organization of lipid raft domains, which might lead to perturbations in various endocytosis pathways, potentially influencing EPSIN3's role. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a potent phosphoinositide 3-kinases (PI3Ks) inhibitor, can induce alterations in endocytic pathways via modulation of PI(4,5)P2 levels, potentially eliciting an indirect effect on EPSIN3 functionality. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Similar to Wortmannin, LY294002 inhibits PI3K, consequently perturbing endocytic trajectories. Its downstream influence on EPSIN3, though indirect, stems from the alteration in phosphoinositide dynamics. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
By sequestering actin monomers, Latrunculin A precludes actin polymerization. Given the intricate interplay between actin dynamics and endocytosis, such modulation might indirectly impinge upon EPSIN3's role. | ||||||